Variant report
Variant | nsv10384 |
---|---|
Chromosome Location | chr1:95752743-95767249 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:95767185..95771086-chr1:95771320..95774034,4 | K562 | blood: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RWDD3-1 | chr1:95752295-95752873 | NONHSAT004657 |
2 | lnc-RWDD3-1 | chr1:95752179-95753228 | XLOC_000307 |
3 | lnc-RWDD3-1 | chr1:95752295-95753608 | NONHSAT004660 |
4 | lnc-RWDD3-1 | chr1:95752295-95753708 | l_93_chr1:95748251-95753708_brain |
No data |
No data |
Variant related genes | Relation type |
---|---|
TNRC6B | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565249617 | chr1:95752876-95752877 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs527841913 | chr1:95752958-95752959 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs181764585 | chr1:95752961-95752962 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs11165366 | chr1:95752995-95752996 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs370671626 | chr1:95753098-95753099 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs186324573 | chr1:95753176-95753177 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs148203296 | chr1:95753193-95753194 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs548974595 | chr1:95753196-95753197 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs568916066 | chr1:95753200-95753201 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs12040856 | chr1:95753295-95753296 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs374038067 | chr1:95753302-95753303 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs570331995 | chr1:95753316-95753317 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs191236711 | chr1:95753318-95753319 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs113892003 | chr1:95753344-95753345 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs141328931 | chr1:95753376-95753377 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs571454152 | chr1:95753384-95753385 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs376106457 | chr1:95753470-95753471 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs533959259 | chr1:95753487-95753488 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs562525370 | chr1:95753512-95753513 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs553720104 | chr1:95753519-95753520 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs60654249 | chr1:95753520-95753521 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs558103971 | chr1:95753552-95753553 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs57734229 | chr1:95753625-95753626 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs138096064 | chr1:95753661-95753662 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs578189274 | chr1:95753689-95753690 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs556129870 | chr1:95753699-95753700 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs575990138 | chr1:95753707-95753708 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs373675848 | chr1:95753719-95753720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545008303 | chr1:95753806-95753807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186746035 | chr1:95753860-95753861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190871765 | chr1:95753861-95753862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183423201 | chr1:95753935-95753936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs58638874 | chr1:95753948-95753949 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs12089283 | chr1:95753972-95753973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549139955 | chr1:95753982-95753983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568981778 | chr1:95753990-95753991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549263831 | chr1:95754001-95754002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs650611 | chr1:95754014-95754015 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs534410258 | chr1:95754026-95754027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551416541 | chr1:95754027-95754028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571504774 | chr1:95754052-95754053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142519854 | chr1:95754060-95754061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574048632 | chr1:95754061-95754062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567388996 | chr1:95754153-95754154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146001268 | chr1:95754174-95754175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375416939 | chr1:95754193-95754194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556195122 | chr1:95754296-95754297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576153752 | chr1:95754327-95754328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12087071 | chr1:95754408-95754409 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs17113320 | chr1:95754413-95754414 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Gastric cancer | 16891809 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:95751800-95754200 | Enhancers | HepG2 | liver |
2 | chr1:95752000-95753400 | Enhancers | Stomach Mucosa | stomach |
3 | chr1:95752200-95755000 | Enhancers | Gastric | stomach |
4 | chr1:95752400-95755000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr1:95753400-95754200 | Weak transcription | Stomach Mucosa | stomach |
6 | chr1:95754200-95754600 | Enhancers | Stomach Mucosa | stomach |
7 | chr1:95755000-95755200 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr1:95755400-95763800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr1:95756600-95756800 | Enhancers | Aorta | Aorta |
10 | chr1:95763800-95764000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr1:95763800-95764000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr1:95763800-95764200 | Active TSS | K562 | blood |